WHO ICTRP trial
A study in non-hospitalized COVID-19 patients to assess safety and effectiveness…
CTRI/2022/01/039426 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/01/039426 |
|---|---|
| Public title | A study in non-hospitalized COVID-19 patients to assess safety and effectiveness of study drug. |
| Scientific title | Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID) - Adapt Out COVID |
| Primary sponsor | National Institute of Allergy and Infectious Diseases |
| Secondary sponsors | PPD Pharmaceutical Development India Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Argentina;Botswana;Brazil;Canada;Chile;Colombia;Costa Rica;Ecuador;Guatemala;Haiti;India;Kenya;Malawi;Mexico;Peru;Philippines;South Africa;Uganda;Ukraine;United States of America;Zambia;Zimbabwe |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: SNG001: SNG001 will be dosed daily for 14 days as this was the duration of dosing in Phase I and II studies. With this dosing schedule data from the SG016 study in which hospitalized patients with confirmed COVID-19 were… |
| Registration date | Jan 14, 2022 |
| Target size | 2200 |
| Secondary IDs | ACTIV-2/A5401, Protocol Final Version 7.0, dated 29Jun2021;NCT04518410 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: